Detalles de la búsqueda
1.
Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome.
Ann Hematol
; 100(7): 1711-1722, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33423077
2.
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.
Haematologica
; 102(2): 308-319, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27758818
3.
Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.
Ann Hematol
; 95(11): 1805-10, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27510179
4.
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.
Hemasphere
; 8(5): e64, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38756352
5.
Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia.
Blood
; 117(26): 7174-84, 2011 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21540460
6.
Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact.
Cytometry B Clin Cytom
; 104(2): 141-150, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34390327
7.
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group.
Cytometry B Clin Cytom
; 104(1): 51-65, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36416672
8.
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet.
Cytometry B Clin Cytom
; 104(1): 15-26, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34894176
9.
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group.
Cytometry B Clin Cytom
; 104(1): 77-86, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34897979
10.
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Cytometry B Clin Cytom
; 104(1): 27-50, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36537621
11.
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial.
Blood
; 116(6): 971-8, 2010 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-20442365
12.
Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML.
Blood Adv
; 6(11): 3294-3303, 2022 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320339
13.
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
Bone Marrow Transplant
; 56(3): 635-645, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33028987
14.
Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring.
Haematologica
; 100(3): e93-6, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25425689
15.
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation.
Haematologica
; 94(11): 1613-7, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19880783
16.
Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemia.
Clin Cancer Res
; 14(17): 5585-93, 2008 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18765552
17.
MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms.
Leukemia
; 38(2): 446-450, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38228682
18.
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms.
Leukemia
; 38(6): 1427-1431, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38632316
19.
Cup-like acute myeloid leukemia: new disease or artificial phenomenon?
Haematologica
; 93(2): 283-6, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18223289
20.
Comment to the response to "severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome".
Ann Hematol
; 92(4): 575-6, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22960851